What if a simple photograph of your retina could reveal more than just your eye health?
The retina offers a unique, non-invasive window into the human body, allowing direct visualization of blood vessels and neural tissue. While retinal imaging has traditionally been used to diagnose eye diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration, growing scientific research is revealing its potential to identify biomarkers associated with cardiovascular, cerebrovascular, neurological, renal, and metabolic conditions.
Over the past decade, AI-powered retinal screening has evolved from research into real-world clinical and commercial applications. Automated image capture, AI-assisted analysis, risk assessment, and report generation have made retinal screening increasingly efficient, accessible, and scalable.
Yet an important question remains: If this technology is already available, how many people actually have access to it for early detection and preventive screening?
What if we reimagined the traditional healthcare workflow, allowing individuals to proactively access AI-powered screening as part of their personal health management, rather than waiting for symptoms or physician-initiated referrals?
Drawing on real-world applications of retinal AI technology across different healthcare systems, as well as firsthand experience navigating its commercialization in Canada, this webinar explores the potential of consumer-initiated preventive screening to improve early detection, support clinical decision-making, and create new opportunities for healthcare innovation.
Key Topics
- What retinal AI technology can realistically achieve today: From detecting multiple retinal diseases to identifying emerging biomarkers associated with systemic health conditions, while recognizing the distinction between validated clinical applications and ongoing research.
- How automated AI screening works: Image capture, AI-assisted analysis, risk assessment, and report generation, and how these technologies can enable more accessible community-based screening.
- The clinical and economic value of earlier detection: Exploring opportunities to improve screening participation, support timely intervention, optimize healthcare resources, and potentially reduce long-term healthcare and societal burdens.
- Integrating consumer-initiated screening into Canadian healthcare: How preventive screening outside conventional clinical settings could complement primary care, specialist referrals, and existing care pathways.
- Bridging the gap between screening and care: How digital health technology can better connect early detection, clinical diagnosis, referral, follow-up, and ongoing health management.
- From innovation to real-world adoption: Sharing firsthand experiences, practical challenges, and lessons learned in advancing retinal AI technology, including regulatory barriers, clinical validation, healthcare workflows, commercialization, and stakeholder engagement.
The Bigger Question
Can we create a healthcare model in which individuals are empowered to take a more active role in early detection and prevention, while remaining connected to professional clinical care?
Through the example of retinal AI, this session invites healthcare professionals, innovators, policymakers, and industry stakeholders to rethink how existing technologies could support a more accessible, proactive, and consumer-empowered healthcare system.
Presented by:
Sirena You, HealthByte Technology Inc.
Sirena You is a Vancouver-based serial entrepreneur, investor, and the founder of HealthByte Technology Inc., a platform advancing consumer-driven, preventative healthcare. She has founded and co-founded multiple companies across technology and innovation sectors, with ventures reaching billion-RMB scale and serving large global user bases.
Her career began in the ultra-high-net-worth market, including 10+ years of selling private jets, where she developed a deep understanding of access, service models, and premium ecosystems. A pivotal turning point came during her time with Human Longevity Inc., a pioneer in genome-based precision healthcare, where she recognized that many of the most advanced health technologies remained accessible only to the wealthy.
This realization reshaped her mission. Today, Sirena is strong advocate for the democratization of healthcare in North America, focused on building and investing in direct-to-consumer (DTC) healthcare platforms that enable individuals to access preventative, data-driven health tools. Her work centers on empowering people to take control of their own health, while contributing to a more sustainable and accessible healthcare system.
Earn One Continuing Education Unit (CEU) for attending this webinar.
Webinar Wednesday attendance is one of the benefits of Digital Health Canada Membership. Not a member yet? Join Digital Health Canada to enjoy Webinar Wednesdays and other benefits of membership.